Impact of therapy with rilmedinine versus atenolol on baroreflectory circulatory regulation in patients with hypertensive disease: association with the diurnal profile of blood pressure profile and the magnitude of antihypertensive effect
https://doi.org/10.18705/1607-419X-2004-10-2-126-130
Abstract
Background. The mechanisms responsible for the antihypertensive effect of selective imidazoline receptor agonists, such as rilmedinine, remain nowadays inadequately explored, improved baroreflectory regulation of the circulatory system in the treatment with antihypertensive drugs makes additional advantages in predicting further progression in patients with hypertensive disease. Aim. To estimate the time course of changes in the vasomotor component of cardiopulmonary baroreflex (CPBR) during acute and chronic therapy with rilmenidine versus atenolol and to study the impact of baroreflectory regulation on the efficiency of further therapy. Results. According to the data of daily monitoring, long-term therapy showed a significant decrease in blood pressure in both groups. Two hours after the use of rilmenidine, the patients showed a heterodirectional changes in the vasomotor component of CPBR whose variability was associated with the efficiency of further 6-month therapy with this drug, which was evaluated by the decrease of the level and variability of the diurnal blood pressure profile, and by the fattens recovery.
About the Authors
O. V. Mamontov
Институт сердечно-сосудистых заболеваний СП6ГМУ им. акад. И.П. Павлова
Russian Federation
Russian Federation
Yu. R. Kasherininov
Институт сердечно-сосудистых заболеваний СП6ГМУ им. акад. И.П. Павлова
Russian Federation
Russian Federation
A. A. Shavarov
Институт сердечно-сосудистых заболеваний СП6ГМУ им. акад. И.П. Павлова
Russian Federation
Russian Federation
A. O. Konradi
Институт сердечно-сосудистых заболеваний СП6ГМУ им. акад. И.П. Павлова
Russian Federation
Russian Federation
References
1. La Rovere M.T. Autonomic markers of prognosis after myocardial Infarction. Gin Set 1996; 91 (Suppl): 133-5.
2. La Rovere M.T., Mortara A., Schwartz P.J. Baroreflex sensitivity. J Cardiovasc Electrophysiol 1995; 6: 761-74.
3. Katsube Y., Saro H., Naka M. et al. Decreased baroreflex sensitivity in patients with stable coronary artery disease is correlated with the severity of coronary narrowing. Am J Cardiol 1996; 78: 1007-10.
4. Head G.A. Baroreflexes and cardiovascular regulation in hypertension J Cardiovasc Pharmacol 1995; 26 (Suppl. 2): S7-16.
5. Head G.A., Burke S.L., Sannajust F.J. Involvement of imidazoline receptors in the baroreflex effects of rilmenidine in conscious rabbits. J Hypertens 2001: 19; 1615-24.
6. Head G.A., Burke S.L. Comparison of renal sympathetic baroreflex effects of rilmenidine and alpha-methylnoradrenaline in the ventrolateral medulla of the rabbit. J Hypertens 2000; 18: 1263-76.
7. Godwin S.J., Torletti C.F., Parkin M.L., Head G.A. Comparison of the baroreceptor-heart rate reflex effects of moxonidine, rilmenidine and clonidine in conscious rabbits. J Auton Nerv Syst 1998: 15; 195-204.
8. Van den Buuse M. Pretreatment with quinpirole inhibits the central antihypertensive effects of rilmenidine and alpha-methyldopa in conscious rats. Eur J Pharmacol 1997; 322: 191-9.
9. Muenter Swift N., Cutler M.J., Fadel P.J. et al. Carotid baroreflex function durum and following voluntary apnea in humans. Am J Physiol Heart Circ Physiol 2003; 285: H2411-9.
10. Mohanty P.K., Sowers J.R., McNamara С., Thames M.D. Reflex vasoconstrictor responses to cardiopulmonary baroreceptor unloading, head-up tilt, and cold pressor testing in elderly mild-to-moderate hypertensives: effect of clonidine. J Cardiovasc Pharmacol 1987: 10 (Suppl. 12): S135-7.
11. Medvedev O.S., Kunduzova O.R., Murashev A.N., Medvedeva N.A. Influence of sino-aortic barodenervation on the cardiovascular effects of imidazoline-like dings. J Auton Nerv Syst 1998; 72: 205-9.
12. McKaigue J.P., Harron D.W. The effects of rilmenidine on tests of autonomic function in humans. Clin Pharmacol Ther 1992; 52: 511-7.
13. Head G.A., Burke S.L. II imidazoline receptors in cardiovascular regulation: the place of rilmenidine. Am J Hypertens 2000: 13: 89S-98S.
14. Mayorov D.N., Burke S.L., Head H.A. Relative Importance of Rostral Ventrolateral Medulla in Sympathoinhibitory Action of Rilmenidine in Conscious and Anesthetized Rabbits J Cardiovasc Pharmacol 2001; 37: 252-61.
15. Tamaki N., Obtani H., Yamashita К. et al. Metabolic activity in the areas of new fillin after thallium-201 reinfection: Comparison with positron emission tomography using fluorine-18-deoxyglucose. J Nucl Med 1991: 32: 673-8.
16. Katoh N., Sheriff D.D., Siu C.O., Sagawa K. Relative importance of four pressoregulatory mechanisms after 10 % bleeding in rabbits. Am J Physiol 1989; 256: H291-6.
17. Nasqez E.S. Contribution of the cardiopulmonary baroreflex control to the cardiovascular regulation in normal and pathophysiological states. Brasil J Med Biol Res 1994: 27: 1043-64.
18. Osterziel K.J., Hanlein K., Willenbrock R., Dietz R.Z. (Interaction between the renin system and parasympathetic nervous system in heart failure). Kardiol 1993: 82: 406-10.
19. Kawano Y., Yoshimi H., Matsuoka H., Omae T. Changes in plasma endothelin-I concentration during blood volume depletion and expansion: role oj the cardiopulmonary baroreflex. Hypertens Res 1995; 18: 43-6.
20. Stevens P.M., Lamb L.I. Effect of lower body negative pressure on the cardiovascular system. Am J Cardiol 1965: 16: 506-15.
21. Скардс Я.В., Витолс А.Я. Гибкий онкометр для определения объема кровотока предплечья и предплечья методом венозной окклнюзионной плетизмографии. Физиол. журн. СССР. 1974: 10: 16-8.
22. Cuspidi С., Michev I., Meani S. et al. Non-dipper treated hypertensive patients do not have increased cardiac structural alterations. Cardiovasc Ultrasound 2003; 14 (1): 1.
23. Head G.A. Central imidazoline- and alpha 2-receptors involved in the cardiovascular actions of centrally acting antihypertensive agents. Ann N Y Acad Sci 1999: 881: 279-86.
24. Head G.A., Chan C.K., Burke S.L. Relationship between imidazoline and alpba2-adrenoceptors involved in the sympatho-inhibitory actions of centrally acting antihypertensive agents. J Auton Nerv Syst 1998; 72: 163-9.
25. Jokasalo E., Enlund H., Halonen P. et al. Factors related to poor control of blood pressure with antihypertensive therapy. Blood Pressure 2002; 12: 22-7.
Review
For citations:
Mamontov O.V., Kasherininov Yu.R., Shavarov A.A., Konradi A.O. Impact of therapy with rilmedinine versus atenolol on baroreflectory circulatory regulation in patients with hypertensive disease: association with the diurnal profile of blood pressure profile and the magnitude of antihypertensive effect. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2004;10(2):126-130. (In Russ.) https://doi.org/10.18705/1607-419X-2004-10-2-126-130
Views:
924
Email this article 